Navigation Links
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Date:4/13/2009

NOVATO, Calif., April 13 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) today announced the appointment of Patrice P. Rioux, M.D., Ph.D., as Chief Medical Officer ("CMO"). Dr. Rioux will be responsible for the clinical and regulatory advancement of Raptor's clinical-stage drug development programs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

Raptor's clinical programs include Delayed-Release Cysteamine ("DR Cysteamine") for the potential treatment of nephropathic cystinosis ("cystinosis"), non-alcoholic steatohepatitis ("NASH") and Huntington's Disease ("Huntington's"), as well as Convivia(TM), for the potential treatment of aldehyde dehydrogenase ("ALDH2") deficiency.

Dr. Rioux has extensive experience as a clinician, researcher, medical director and regulatory specialist. Most recently, Dr. Rioux was CMO of FerroKin Biosciences, an early-stage developer of iron chelator for treatment of anemias. Prior to that, he was CMO and Vice President Clinical/Regulatory for Edison Pharmaceuticals, which focused on developing drugs to treat inherited and acquired energy impairment diseases. Dr. Rioux' three-decade career includes industry experience at companies such as Repligen Corp., Arrow International, Variagenics, Inc., Biogen and GRP (Groupement de Recherche en Pharmacologie). He previously was a researcher in Clinical Research and Epidemiology at INSERM (Institut National de la Sante et de la Recherche Medicale), a French organization that supports national research in the medical field, from 1975 to 1995. Educated in France, Dr. Rioux has an M.D., a Ph.D. in Mathematical Statisics, and a Masters in Pharmacology.

Christopher M. Starr, Ph.D.,
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
2. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
3. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
4. Raptor Pharmaceuticals Provides Update on Targeting Platforms
5. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
6. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
7. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Strativa Pharmaceuticals Provides Product Pipeline Update
10. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
11. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013  Caradigm today announced the availability ... to help healthcare organizations efficiently manage clinician ... their compliance with data privacy regulations. The ... in the delivery of advanced role lifecycle ... systems. (Photo: http://photos.prnewswire.com/prnh/20130619/SF34463LOGO ...
(Date:6/19/2013)... 19, 2013 ... DrugPatentWatch to its extensive list of ...      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) , ... pharmaceutical, drug patents and their expirations. ... business functions of patent agents and ...
(Date:6/19/2013)... BIRMINGHAM, Ala. , June 19, 2013 ... technology solutions and services to health plans, integrated delivery ... for its Medical Drug Management Service (MDMS) ... to clinically edit and automate the pricing of medical ... to gain efficiencies by automating their medical drug claims ...
Breaking Medicine Technology:Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3Drug Patent Watch 2Drug Patent Watch 3Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3
... Nov. 10, 2010 MDG Medical Incorporated, a North ... TCG, a Wisconsin based provider of automated packaging equipment, ... needs in the long term care market. ... http://photos.prnewswire.com/prnh/20101109/DC97296LOGO ) Duane Chudy, CEO ...
... H1N1 flu hospitalization rates for African-Americans, Hispanics, and American ... rates for Whites during the 2009-2010 flu season, according ... from the Trust for America,s Health (TFAH). At the ... were lower for African Americans and Hispanics than for ...
Cached Medicine Technology:MDG and TCGRx Team Up to Service Long Term Care Market 2New Report Finds H1N1 Hospitalization Rates Higher But Vaccination Rates Lower for Minorities 2New Report Finds H1N1 Hospitalization Rates Higher But Vaccination Rates Lower for Minorities 3New Report Finds H1N1 Hospitalization Rates Higher But Vaccination Rates Lower for Minorities 4
(Date:6/19/2013)... Kailua Kona, HI (PRWEB) June 19, 2013 ... and coordination company is dedicated to being an effective ... Hawaii wedding, reception needs. They have partnered up with ... experienced advice and discounts on most of Hawaii’s activities. ... that shows how clients can get the lowest prices ...
(Date:6/19/2013)... According to Transparency Market Research “Endoscopy ... Analysis and Forecast, 2011 – 2017,” the global endoscopy ... year 2011 and is expected to reach USD 10.8 ... from 2011 to 2017. Flexible endoscopes formed the largest ... 2,201 million for the year 2011. , Related Report ...
(Date:6/19/2013)... the mantra of neurologists treating stroke victims has been "time ... room quickly to receive a drug that dissolves the stroke-causing ... brain tissue is saved or lost. , But ... of giving the intravenous drug known as a tissue ... ischemic (clot-caused), stroke, the most common type of stroke. ...
(Date:6/19/2013)... Il. A Loyola University Chicago Niehoff School of ... to study whether Vitamin D can improve mood in ... also will examine whether vitamin D supplementation can reduce ... diabetes. The grant is from the National Institute of ... Principal investigator Sue M. Penckofer, PhD, RN and colleagues ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 AquaPrint Solutions in ... Pub & Grub with a newly-designed Harley Davidson motorcycle gas ... of AquaPrint Solutions with an idea of taking a split ... the ages and transforming it into a work of art. ... Pub & Grub several toilet seats that had been dipped ...
Breaking Medicine News(10 mins):Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3Health News:Loyola receives $1.5 million grant to study vitamin D for diabetes and depression 2Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2
... News) -- Elevated blood levels of a central nervous system ... by a lack of oxygen, according to a new study. ... can also help doctors assess the effectiveness of a body-cooling ... Johns Hopkins researchers said. GFAP is specific to central ...
... HealthDay Reporter , THURSDAY, Oct. 13 (HealthDay News) ... epilepsy remain free of seizures 10 years later, a new ... medication, and only when drugs can,t control seizures -- often ... for surgery. This study suggests that some patients with focal ...
... procedure that measures the amount of oxygen in the ... detect critical congenital heart disease (CCHD) in infants, and ... standard for CCHD diagnosis, according to a new research ... of Pediatrics (AAP) National Conference and Exhibition (NCE) in ...
... THURSDAY, Oct. 13 (HealthDay News) -- Smoky, inefficient indoor cooking ... developing nations contribute to 2 million deaths a year, according ... affects about 3 billion people, or nearly half the world,s ... in a commentary published in the current issue of the ...
... CHAMPAIGN, Ill. What if you could trace the history of ... camera, you could learn what factory made the ingredients in your ... or even how to recycle the phone. You could follow the ... along the way to ensure that the medicine you,re taking isn,t ...
... 13 (HealthDay News) -- Nearly one in four Americans with ... undiagnosed psoriatic arthritis, according to a new study. This ... United States who have been diagnosed with the disease, a ... and can lead to joint destruction and disability. For ...
Cached Medicine News:Health News:Protein May Help Spot Newborns With Brain Damage 2Health News:For Many, Epilepsy Surgery Effective Long-Term 2Health News:For Many, Epilepsy Surgery Effective Long-Term 3Health News:Globally, 2 Million Deaths a Year Linked to Smoky Stoves 2Health News:Packaging expert sees a social revolution in the evolving barcode 2Health News:Packaging expert sees a social revolution in the evolving barcode 3Health News:1 in 4 With Psoriasis May Have Undiagnosed Arthritis 2
Provides immediate access to comprehensive coverage of more than 325 I.V. drugs, blood products, and solutions....
... a comprehensive, authoritative drug reference to ... overdose management, Canadian drug names, OTC ... drug references and tools is included ... (ED, PRIMARY CARE PLUS, CRC, RN, ...
... patients and health consumers from the trusted ... in MedMaster includes why the medication is ... side effects and warning signs of adverse ... information on what to do if a ...
Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
Medicine Products: